US Stock MarketDetailed Quotes

X4 Pharmaceuticals (XFOR)

Watchlist

4.340
-0.160-3.56%

Close May 12 16:00 ET

4.400
+0.060+1.38%

Post 19:38 ET

409.35MMarket Cap-2.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals (XFOR) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-58.47%-19.6M

34.59%-85.62M

52.94%-15.53M

18.25%-27.82M

1.24%-29.9M

63.19%-12.37M

-35.63%-130.9M

-18.91%-33M

-63.40%-34.03M

-41.32%-30.28M

Net income from continuing operations

-7,277.66%-20.24M

-111.48%-79.2M

39.92%-23.93M

18.75%-29.82M

-128.34%-25.74M

100.54%282K

62.98%-37.45M

-108.16%-39.82M

-1,492.02%-36.7M

263.04%90.83M

Operating gains losses

99.26%-80K

88.05%-12.78M

-99.33%18K

-63.73%676K

97.89%-2.64M

-178.74%-10.83M

-1,411.56%-106.93M

142.14%2.67M

107.41%1.86M

-519.34%-125.22M

Depreciation and amortization

-53.15%223K

60.43%1.28M

-18.32%223K

-16.48%223K

82.99%355K

667.74%476K

89.98%796K

340.32%273K

156.73%267K

53.97%194K

Other non cash items

7.10%498K

86.46%3.36M

-22.03%368K

152.69%940K

264.83%1.59M

-11.09%465K

-20.93%1.8M

0.21%472K

-41.51%372K

-29.04%435K

Change In working capital

26.46%-2.41M

-196.30%-2.58M

361.37%5.52M

63.47%-606K

-501.53%-4.21M

-256.94%-3.28M

677.62%2.68M

122.32%1.2M

-146.86%-1.66M

-32.21%1.05M

-Change in receivables

-196.43%-541K

146.45%497K

129.72%318K

--254K

---636K

--561K

---1.07M

--0

-Change in inventory

41.91%-158K

41.00%-1.66M

-7.26%-399K

43.62%-910K

90.25%-81K

---272K

---2.82M

---372K

---1.61M

---831K

-Change in prepaid assets

287.06%778K

521.96%4.25M

758.75%3.39M

309.45%421K

-28.57%240K

-81.07%201K

149.85%683K

71.90%-514K

-905.00%-201K

120.93%336K

-Change in payables and accrued expense

59.05%-2.17M

-172.70%-5M

-17.80%2.81M

72.99%711K

-279.77%-3.22M

-518.45%-5.31M

142.19%6.88M

205.56%3.42M

-89.37%411K

-47.80%1.79M

-Change in other current liabilities

5.47%-259K

-73.31%-1.74M

-13.31%-298K

-245.88%-882K

-16.26%-286K

-14.17%-274K

10.99%-1M

10.54%-263K

17.21%-255K

10.87%-246K

-Change in other working capital

-103.26%-59K

--1.09M

---296K

---200K

---229K

--1.81M

----

Cash from discontinued investing activities

Operating cash flow

-58.47%-19.6M

34.59%-85.62M

52.94%-15.53M

18.25%-27.82M

1.24%-29.9M

63.19%-12.37M

-35.63%-130.9M

-18.91%-33M

-63.40%-34.03M

-41.32%-30.28M

Investing cash flow

Cash flow from continuing investing activities

713.51%19.25M

-87.83%8.15M

295.44%16.85M

-79.98%-28.67M

-76.14%23.11M

41.04%-3.14M

550.11%66.99M

-78.38%-8.62M

-208.88%-15.93M

2,083.25%96.86M

Net PPE purchase and sale

----

--0

-443.33%-326K

-17.14%-41K

-1,050.00%-92K

-1,575.00%-134K

Net intangibles purchase and sale

--0

57.14%-3M

--0

---3M

---7M

--0

---7M

Net investment purchase and sale

14,050.72%19.25M

136.35%11.15M

296.38%16.85M

-81.03%-28.67M

2,401.99%23.11M

97.38%-138K

-107.00%-30.68M

-78.82%-8.58M

-207.57%-15.84M

79.41%-1M

Net other investing changes

----

--105M

--0

----

Cash from discontinued investing activities

Investing cash flow

713.51%19.25M

-87.83%8.15M

295.44%16.85M

-79.98%-28.67M

-76.14%23.11M

41.04%-3.14M

550.11%66.99M

-78.38%-8.62M

-208.88%-15.93M

2,083.25%96.86M

Financing cash flow

Cash flow from continuing financing activities

1,075.85%238.63M

108,116.30%146.09M

86.91M

-72.07%5.63M

-77.07%20.29M

39.18%135K

-70.93%20.16M

Net issuance payments of debt

----

--0

----

-2.13%20M

--0

5,149.34%20M

Net common stock issuance

----

--238.53M

91,920.13%145.99M

54,586.16%86.95M

----

--0

98.15%-159K

-98.09%159K

--0

Proceeds from stock option exercised by employees

--2K

-66.67%98K

----

--46K

--0

-96.63%294K

----

Cash from discontinued financing activities

Financing cash flow

--2K

1,075.85%238.63M

108,116.30%146.09M

--86.91M

-72.07%5.63M

--0

-77.07%20.29M

39.18%135K

--0

-70.93%20.16M

Net cash flow

Beginning cash position

285.75%217.85M

-43.66%56.48M

-28.27%70.44M

-72.96%40.02M

-33.02%41.04M

-43.66%56.48M

-18.52%100.25M

-25.94%98.2M

7.67%148M

-35.12%61.27M

Current changes in cash

97.78%-345K

469.50%161.16M

455.38%147.41M

160.88%30.41M

-101.33%-1.16M

60.16%-15.51M

-90.64%-43.62M

-27.70%-41.48M

-945.21%-49.96M

101.59%86.74M

Effect of exchange rate changes

-127.78%-20K

236.54%213K

101.23%3K

-100.61%-1K

872.22%139K

222.03%72K

-257.58%-156K

-292.13%-244K

329.17%165K

-200.00%-18K

End cash Position

429.93%217.49M

285.75%217.85M

-28.27%70.44M

-72.96%40.02M

-33.02%41.04M

-43.66%56.48M

-25.94%98.2M

7.67%148M

Free cash flow

-27.53%-19.6M

35.89%-88.62M

53.00%-15.53M

18.47%-27.82M

20.07%-29.9M

54.34%-15.37M

-43.13%-138.23M

-18.91%-33.04M

-63.77%-34.12M

-74.55%-37.41M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-58.47%-19.6M	34.59%-85.62M	52.94%-15.53M	18.25%-27.82M	1.24%-29.9M	63.19%-12.37M	-35.63%-130.9M	-18.91%-33M	-63.40%-34.03M	-41.32%-30.28M
Net income from continuing operations	-7,277.66%-20.24M	-111.48%-79.2M	39.92%-23.93M	18.75%-29.82M	-128.34%-25.74M	100.54%282K	62.98%-37.45M	-108.16%-39.82M	-1,492.02%-36.7M	263.04%90.83M
Operating gains losses	99.26%-80K	88.05%-12.78M	-99.33%18K	-63.73%676K	97.89%-2.64M	-178.74%-10.83M	-1,411.56%-106.93M	142.14%2.67M	107.41%1.86M	-519.34%-125.22M
Depreciation and amortization	-53.15%223K	60.43%1.28M	-18.32%223K	-16.48%223K	82.99%355K	667.74%476K	89.98%796K	340.32%273K	156.73%267K	53.97%194K
Other non cash items	7.10%498K	86.46%3.36M	-22.03%368K	152.69%940K	264.83%1.59M	-11.09%465K	-20.93%1.8M	0.21%472K	-41.51%372K	-29.04%435K
Change In working capital	26.46%-2.41M	-196.30%-2.58M	361.37%5.52M	63.47%-606K	-501.53%-4.21M	-256.94%-3.28M	677.62%2.68M	122.32%1.2M	-146.86%-1.66M	-32.21%1.05M
-Change in receivables	-196.43%-541K	146.45%497K	129.72%318K	--254K	---636K	--561K	---1.07M	---1.07M	--0	--0
-Change in inventory	41.91%-158K	41.00%-1.66M	-7.26%-399K	43.62%-910K	90.25%-81K	---272K	---2.82M	---372K	---1.61M	---831K
-Change in prepaid assets	287.06%778K	521.96%4.25M	758.75%3.39M	309.45%421K	-28.57%240K	-81.07%201K	149.85%683K	71.90%-514K	-905.00%-201K	120.93%336K
-Change in payables and accrued expense	59.05%-2.17M	-172.70%-5M	-17.80%2.81M	72.99%711K	-279.77%-3.22M	-518.45%-5.31M	142.19%6.88M	205.56%3.42M	-89.37%411K	-47.80%1.79M
-Change in other current liabilities	5.47%-259K	-73.31%-1.74M	-13.31%-298K	-245.88%-882K	-16.26%-286K	-14.17%-274K	10.99%-1M	10.54%-263K	17.21%-255K	10.87%-246K
-Change in other working capital	-103.26%-59K	--1.09M	---296K	---200K	---229K	--1.81M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-58.47%-19.6M	34.59%-85.62M	52.94%-15.53M	18.25%-27.82M	1.24%-29.9M	63.19%-12.37M	-35.63%-130.9M	-18.91%-33M	-63.40%-34.03M	-41.32%-30.28M
Investing cash flow
Cash flow from continuing investing activities	713.51%19.25M	-87.83%8.15M	295.44%16.85M	-79.98%-28.67M	-76.14%23.11M	41.04%-3.14M	550.11%66.99M	-78.38%-8.62M	-208.88%-15.93M	2,083.25%96.86M
Net PPE purchase and sale	----	--0	--0	--0	--0	--0	-443.33%-326K	-17.14%-41K	-1,050.00%-92K	-1,575.00%-134K
Net intangibles purchase and sale	--0	57.14%-3M	--0	--0	--0	---3M	---7M	--0	--0	---7M
Net investment purchase and sale	14,050.72%19.25M	136.35%11.15M	296.38%16.85M	-81.03%-28.67M	2,401.99%23.11M	97.38%-138K	-107.00%-30.68M	-78.82%-8.58M	-207.57%-15.84M	79.41%-1M
Net other investing changes	----	----	----	----	----	----	--105M	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	713.51%19.25M	-87.83%8.15M	295.44%16.85M	-79.98%-28.67M	-76.14%23.11M	41.04%-3.14M	550.11%66.99M	-78.38%-8.62M	-208.88%-15.93M	2,083.25%96.86M
Financing cash flow
Cash flow from continuing financing activities	2K	1,075.85%238.63M	108,116.30%146.09M	86.91M	-72.07%5.63M	0	-77.07%20.29M	39.18%135K	0	-70.93%20.16M
Net issuance payments of debt	----	--0	--0	--0	----	----	-2.13%20M	--0	--0	5,149.34%20M
Net common stock issuance	----	--238.53M	91,920.13%145.99M	54,586.16%86.95M	----	----	--0	98.15%-159K	-98.09%159K	--0
Proceeds from stock option exercised by employees	--2K	-66.67%98K	----	----	--46K	--0	-96.63%294K	----	----	----
Cash from discontinued financing activities
Financing cash flow	--2K	1,075.85%238.63M	108,116.30%146.09M	--86.91M	-72.07%5.63M	--0	-77.07%20.29M	39.18%135K	--0	-70.93%20.16M
Net cash flow
Beginning cash position	285.75%217.85M	-43.66%56.48M	-28.27%70.44M	-72.96%40.02M	-33.02%41.04M	-43.66%56.48M	-18.52%100.25M	-25.94%98.2M	7.67%148M	-35.12%61.27M
Current changes in cash	97.78%-345K	469.50%161.16M	455.38%147.41M	160.88%30.41M	-101.33%-1.16M	60.16%-15.51M	-90.64%-43.62M	-27.70%-41.48M	-945.21%-49.96M	101.59%86.74M
Effect of exchange rate changes	-127.78%-20K	236.54%213K	101.23%3K	-100.61%-1K	872.22%139K	222.03%72K	-257.58%-156K	-292.13%-244K	329.17%165K	-200.00%-18K
End cash Position	429.93%217.49M	285.75%217.85M	285.75%217.85M	-28.27%70.44M	-72.96%40.02M	-33.02%41.04M	-43.66%56.48M	-43.66%56.48M	-25.94%98.2M	7.67%148M
Free cash flow	-27.53%-19.6M	35.89%-88.62M	53.00%-15.53M	18.47%-27.82M	20.07%-29.9M	54.34%-15.37M	-43.13%-138.23M	-18.91%-33.04M	-63.77%-34.12M	-74.55%-37.41M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm